MedTrace Logo

Family Lifestyle Overweight Prevention Program-Physical Activity Only

NCT04396769 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 491

Last updated 2020-05-22

No results posted yet for this study

Summary

This randomized control trial evaluates the physical activity component of the Family Lifestyle Overweight Prevention Program compared to physical education class as usual among Hispanic middle school students.

Conditions

Interventions

BEHAVIORAL

FLOW-PA

Classes were designed to provide the opportunity to be physically activity at a moderate-vigorous level. Each station included exercise options to accommodate varying fitness levels and offer students choice. Heart rate monitors provided consistent biofeedback to students throughout the intervention. Participants were evaluated based on the number of minutes they spent each class between 60-80% of their maximal heart rate. Games were intermixed either as a station or as a break in the circuit (e.g. short game of tag half-way through the workout) to make physical activity enjoyable and engaging.

BEHAVIORAL

PE class as usual

PE teachers were instructed to teach class as usual. Research staff were not involved in class activities or instruction. In this school district PE class as usual includes sports-based instruction in which students learn the rules to games and then practice playing.

Sponsors & Collaborators

  • Baylor College of Medicine

    collaborator OTHER

  • University of Houston

    lead OTHER

Principal Investigators

  • Craig A Johnston, PhD · University of Houston

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-15
Primary Completion
2014-06-01
Completion
2014-06-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04396769 on ClinicalTrials.gov